Wuhan Oukai Pharmaceutical

Wuhan Oukai Pharmaceutical Technology Co., Ltd. is a research-oriented pharmaceutical company based in Wuhan's "Optics Valley," China. Founded in 2012, the company specializes in the development, manufacture, and sale of high-end pharmaceutical intermediates, fine chemicals, and active pharmaceutical ingredients (APIs). Oukai operates primarily as a specialized CRO and CMO, offering expertise in heterocyclic chemistry, chiral synthesis, and process optimization for complex organic molecules. Its product portfolio includes critical chemical building blocks for several blockbuster targeted therapies, particularly in the oncology space for inhibitors of BTK, EGFR, and PARP. The company serves a global client base, providing custom synthesis services from laboratory R&D to commercial-scale production.